Viewing Study NCT04562467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-31 @ 11:07 AM
Study NCT ID: NCT04562467
Status: COMPLETED
Last Update Posted: 2024-04-02
First Post: 2020-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiovascular Diseases View
None Cardiovascular Risk Factor View
None Triglycerides High View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardiometabolic Risk View
None Type 2 Diabetes View
None Icosapent Ethyl View
None Omega-3 View
None Vascular Diseases View
None Progenitor Cells View
None Vascular Disease View
None Blood Lipids View